Literature DB >> 16362162

Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA.

Hideki Ueda1,2, Eiji Ishimura3, Takayuki Yunoki4, Takao Tsuchida3, Naoki Matsumoto3, Syuichi Jono3, Yasuo Imanishi4, Masaaki Inaba4, Yoshiki Nishizawa4.   

Abstract

We describe a 75-year-old man with tubulointerstitial nephritis (TIN) with myeloperoxidase (MPO)-antineutrophil antibody (ANCA) and proteinase-3 (PR3)-ANCA. He had a slight fever and eruption with itching after taking cimetidine (prescribed after gastrectomy for gastric cancer) and he was admitted to a nearby hospital. There, he showed proteinuria, serum creatinine (sCr) of 2.9 mg/dl, and creatinine clearance (Ccr) of 44 ml/min per 1.73 m2. His MPO-ANCA titer was 267 EU, and PR3-ANCA titer was 112 EU. Abnormal concentrations in bilateral kidneys were found by gallium scintigraphy. For these reasons, he was transferred to our hospital. Percutaneous renal biopsy was performed after admission. Severe tubular atrophy, mild interstitial fibrosis, and severe mononuclear cell infiltration of the interstitium were noted. Drug-induced renal impairment was suspected, and cimetidine administration was withdrawn. Lymphocyte stimulation tests (DLSTs) were performed. The cimetidine titer was positive, at 2,537 cpm. After the withdrawal of cimetidine, the PR3-ANCA titer was reduced gradually, and, next, the MPO-ANCA titer was also reduced. The sCr level was reduced to 1.2 mg/dl. In summary, we report herein the first case of cimetidine-induced TIN associated with both MPO-ANCA and PR3-ANCA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362162     DOI: 10.1007/s10157-005-0382-7

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  10 in total

1.  Tubulointerstitial nephritis with anti-neutrophil cytoplasmic antibody following indomethacin treatment.

Authors:  N Sakai; T Wada; M Shimizu; C Segawa; K Furuichi; K i Kobayashi; H Yokoyama
Journal:  Nephrol Dial Transplant       Date:  1999-11       Impact factor: 5.992

2.  A case of membranous glomerulonephritis associated with gastric cancer.

Authors:  M Waki; E Ishimura; H Morii; S Sakai; S Saitoh; T Kobayashi; M Matsuyoshi; S Wada; H Tsukuda; M Emoto; A Shioi; Y Nishizawa; K Goto; M Sakurai; K Wakasa; Y Yamashita; T Inoue; Y Y Chung; M Sowa
Journal:  Osaka City Med J       Date:  1997-06

3.  Renal vasculitis associated with ciprofloxacin.

Authors:  D J Shih; S M Korbet; J J Rydel; M M Schwartz
Journal:  Am J Kidney Dis       Date:  1995-09       Impact factor: 8.860

4.  Phenytoin-associated vasculitis and ANCA positivity: a case report.

Authors:  R G Parry; P Gordon; J C Mason; N J Marley
Journal:  Nephrol Dial Transplant       Date:  1996-02       Impact factor: 5.992

Review 5.  Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature.

Authors:  T Kitahara; K Hiromura; A Maezawa; K Ono; N Narabara; S Yano; T Naruse; K Takenouchi; Y Yasumoto
Journal:  Clin Nephrol       Date:  1997-05       Impact factor: 0.975

6.  Cephotaxime-associated allergic interstitial nephritis and MPO-ANCA positive vasculitis.

Authors:  S Feriozzi; A O Muda; V Gomes; M Montanaro; T Faraggiana; E Ancarani
Journal:  Ren Fail       Date:  2000-03       Impact factor: 2.606

7.  Acute interstitial nephritis, omeprazole and antineutrophil cytoplasmic antibodies.

Authors:  S Singer; R G Parry; H A Deodhar; J N Barnes
Journal:  Clin Nephrol       Date:  1994-10       Impact factor: 0.975

8.  A case of cimetidine-induced acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody.

Authors:  T Kitahara; K Hiromura; M Sugawara; J Hirato; S Sato; K Ueki; A Maezawa; S Yano; Y Nojima; T Naruse
Journal:  Am J Kidney Dis       Date:  1999-02       Impact factor: 8.860

9.  Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy.

Authors:  K M Dolman; R O Gans; T J Vervaat; G Zevenbergen; D Maingay; R E Nikkels; A J Donker; A E von dem Borne; R Goldschmeding
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

10.  Autoantibodies to leucocyte antigens in hydralazine-associated nephritis.

Authors:  G Almroth; S Eneström; J Hed; I Samuelsson; P Sjöström
Journal:  J Intern Med       Date:  1992-01       Impact factor: 8.989

  10 in total
  4 in total

1.  Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.

Authors:  Sun Moon Kim; Song-Yi Choi; Seon Young Kim; Jinhyun Kim
Journal:  Rheumatol Int       Date:  2019-09-24       Impact factor: 2.631

2.  A Japanese case of proteinase 3 antineutrophil cytoplasmic autoantibody-associated pauci-immune-type crescentic glomerulonephritis without valvular endocarditis.

Authors:  Satoshi Morimoto; Fumitaka Nakajima; Tatsuyori Morita; Kazunori Someya; Makiko Kusabe; Mitsutaka Nakahigashi; Takatomi Yurugi; Masayoshi Fukui; Takayuki Okamoto; Fusakazu Jo; Nagaoki Toyoda; Toshiji Iwasaka
Journal:  Clin Exp Nephrol       Date:  2011-02-18       Impact factor: 2.801

3.  Rare Case of Renal Limited Dual Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Double Trouble!

Authors:  Elenjickal Elias John; Sanjeet Roy; Selvin Sundar Raj Mani; Jeethu Joseph Eapen; Utkarash Mishra; Santosh Varughese
Journal:  Eur J Case Rep Intern Med       Date:  2022-05-10

Review 4.  Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report.

Authors:  Keita Morimoto; Go Kanzaki; Takahito Niikura; Kentaro Koike; Nanae Matsuo; Yukio Maruyama; Nobuo Tsuboi; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2021-08-30       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.